[Obesity in the COVID era: A global health challenge]. / Obesidad en tiempos de COVID-19. Un desafío de salud global.
Endocrinol Diabetes Nutr
; 68(2): 123-129, 2021 Feb.
Article
em Es
| MEDLINE
| ID: mdl-38620799
ABSTRACT
Obesity is a chronic disease that leads to an increased risk of mortality and morbidity, and the impact of the COVID-19 pandemic may create a new health challenge. There is clear evidence showing that some biological and social factors associated with obesity involve an increased risk of COVID-19 infection, hospitalization, and greater severity compared to people with normal weight. Undoubtedly, obesity involves a low-grade proinflammatory state that produces a dysregulation of the immune system that compromises its ability to respond to respiratory infection by COVID-19 and so produces a worsening of the disease. In this review, the main epidemiological and pathophysiological data that associate obesity with COVID-19 are described.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
Es
Revista:
Endocrinol Diabetes Nutr
/
Endocrinol. diabetes nutr. (Ed. impr.)
/
Endocrinologia, diabetes y nutricion (Ed. impresa)
Ano de publicação:
2021
Tipo de documento:
Article